At-BC8-B10 Trial Before Stem Cell Transplant
Phase 1/2
75
about 11 years
18–75
1 site in WA
What this study is about
This trial is testing a treatment called At-BC8-B10 before donor stem cell transplant in people with high-risk leukemia. The goal is to find the best dose of this treatment and see how it affects patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Pretargeted Radioimmunotherapy
- 2.Receive Total-Body Irradiation
- 3.Take Cyclosporine
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ciclosporin, Antineoplastic Agent [TC] (Nucleic Acid Synthesis Inhibitors), Immunological Agents (Enzyme Inhibitors)
injection, intravenous, injection (Injection)
Primary: Incidence of grades III/IV Bearman regimen-related toxicity
Secondary: Disease-free survival, Non-relapse mortality, Overall survival
diagnostic, imaging, radiation
Oncology